General MedicationsTRANSDERMALGeneric

TRANSDERM-NITRO

NITROGLYCERIN

Standard Dose

0.8MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview TRANSDERM-NITRO is listed in Drugs@FDA under application 020144 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient NITROGLYCERIN Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 0.8MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NOVARTIS Submission history Latest submission status date: 2000-09-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRANSDERM-NITRO is listed in Drugs@FDA under application 020144 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NITROGLYCERIN Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 0.8MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NOVARTIS Submission history Latest submission status date: 2000-09-20 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.